DULOXETINE HYDROCHLORIDE

DULOXETINE HYDROCHLORIDE was reported 71546 times

These side effects are most commonly reported by patients taking DULOXETINE HYDROCHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 5654
1 NAUSEA 5344
2 FATIGUE 5240
3 OFF LABEL USE 4568
4 HEADACHE 4048
5 PAIN 4037
6 DIARRHOEA 3613
7 DIZZINESS 3330
8 FALL 3055
9 VOMITING 2710
10 ARTHRALGIA 2568
11 DYSPNOEA 2547
12 TOXICITY TO VARIOUS AGENTS 2444
13 DEPRESSION 2296
14 DRUG INTERACTION 2263
15 COMPLETED SUICIDE 2231
16 ANXIETY 2128
17 ASTHENIA 2117
18 SOMNOLENCE 2076
19 MALAISE 1953
20 CONDITION AGGRAVATED 1849
21 HYPERHIDROSIS 1847
22 PAIN IN EXTREMITY 1840
23 INSOMNIA 1836
24 DEATH 1827
25 PRODUCT DOSE OMISSION ISSUE 1799
26 PNEUMONIA 1735
27 CONSTIPATION 1691
28 BACK PAIN 1673
29 PRURITUS 1652
30 GAIT DISTURBANCE 1556
31 COUGH 1552
32 WEIGHT DECREASED 1548
33 PRODUCT USE IN UNAPPROVED INDICATION 1525
34 RASH 1523
35 TREMOR 1508
36 CONFUSIONAL STATE 1504
37 FEELING ABNORMAL 1461
38 DECREASED APPETITE 1421
39 WEIGHT INCREASED 1372
40 ACUTE KIDNEY INJURY 1350
41 URINARY TRACT INFECTION 1315
42 SUICIDAL IDEATION 1305
43 ABDOMINAL PAIN 1275
44 HYPERTENSION 1255
45 COVID-19 1250
46 HYPOTENSION 1243
47 MEMORY IMPAIRMENT 1215
48 ABDOMINAL PAIN UPPER 1156
49 SEROTONIN SYNDROME 1153
50 PYREXIA 1145
51 PARAESTHESIA 1113
52 MUSCLE SPASMS 1051
53 OVERDOSE 1043
54 NEUROPATHY PERIPHERAL 1000
55 DRUG HYPERSENSITIVITY 997
56 HYPOAESTHESIA 986
57 PERIPHERAL SWELLING 986
58 NASOPHARYNGITIS 949
59 BLOOD PRESSURE INCREASED 945
60 CHRONIC KIDNEY DISEASE 932
61 HYPERSENSITIVITY 913
62 LOSS OF CONSCIOUSNESS 908
63 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 900
64 ABDOMINAL DISCOMFORT 893
65 BALANCE DISORDER 873
66 CHEST PAIN 845
67 MYALGIA 837
68 MIGRAINE 829
69 ILLNESS 824
70 INTENTIONAL OVERDOSE 823
71 NIGHTMARE 823
72 GASTROOESOPHAGEAL REFLUX DISEASE 821
73 MUSCULAR WEAKNESS 815
74 DRUG INTOLERANCE 791
75 HALLUCINATION 783
76 ALOPECIA 779
77 INJECTION SITE PAIN 749
78 SEDATION 745
79 RENAL FAILURE 740
80 WITHDRAWAL SYNDROME 718
81 VISION BLURRED 717
82 SEIZURE 708
83 ANAEMIA 706
84 NEPHROLITHIASIS 704
85 SINUSITIS 698
86 ASTHMA 684
87 DEHYDRATION 683
88 DRY MOUTH 680
89 DRUG ABUSE 679
90 INFLUENZA 677
91 SUICIDE ATTEMPT 677
92 RHEUMATOID ARTHRITIS 675
93 INFECTION 673
94 PRODUCT USE ISSUE 665
95 INCORRECT DOSE ADMINISTERED 645
96 MUSCULOSKELETAL STIFFNESS 643
97 CONTUSION 641
98 TACHYCARDIA 641
99 SLEEP DISORDER 640
100 DEPRESSED MOOD 631
101 COMA 629
102 PALPITATIONS 626
103 PSORIASIS 607
104 HYPONATRAEMIA 605
105 URTICARIA 605
106 SYNCOPE 602
107 DYSPEPSIA 598
108 DRUG WITHDRAWAL SYNDROME 595
109 AGITATION 581
110 OROPHARYNGEAL PAIN 578
111 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 577
112 VISUAL IMPAIRMENT 576
113 DISTURBANCE IN ATTENTION 567
114 INTENTIONAL PRODUCT MISUSE 564
115 ARTHRITIS 543
116 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 543
117 JOINT SWELLING 542
118 ERYTHEMA 538
119 DYSPHONIA 534
120 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 532
121 PRODUCT SUBSTITUTION ISSUE 529
122 ABDOMINAL DISTENSION 528
123 HEART RATE INCREASED 521
124 SWELLING FACE 518
125 SEPSIS 515
126 THERAPY INTERRUPTED 513
127 DYSPHAGIA 512
128 FIBROMYALGIA 508
129 CHILLS 503
130 GENERAL PHYSICAL HEALTH DETERIORATION 503
131 VERTIGO 503
132 OXYGEN SATURATION DECREASED 501
133 INTENTIONAL PRODUCT USE ISSUE 494
134 CHEST DISCOMFORT 491
135 BRONCHITIS 487
136 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 484
137 OEDEMA PERIPHERAL 482
138 COGNITIVE DISORDER 479
139 MOBILITY DECREASED 476
140 CEREBROVASCULAR ACCIDENT 475
141 CARDIAC ARREST 474
142 DELIRIUM 473
143 HOSPITALISATION 472
144 FOETAL EXPOSURE DURING PREGNANCY 471
145 AMNESIA 469
146 OSTEOARTHRITIS 465
147 MULTIPLE SCLEROSIS RELAPSE 462
148 PSORIATIC ARTHROPATHY 460
149 BLOOD GLUCOSE INCREASED 458
150 IRRITABILITY 453
151 PNEUMONIA ASPIRATION 451
152 HOT FLUSH 450
153 NECK PAIN 450
154 DEPRESSED LEVEL OF CONSCIOUSNESS 441
155 STRESS 435
156 GASTROINTESTINAL DISORDER 431
157 ATRIAL FIBRILLATION 427
158 DRY SKIN 426
159 EYE PAIN 410
160 SWOLLEN TONGUE 409
161 NEUTROPENIA 400
162 DYSKINESIA 398
163 SWELLING 391
164 MULTIPLE SCLEROSIS 388
165 DRUG DOSE OMISSION 387
166 FLUSHING 387
167 INFLUENZA LIKE ILLNESS 387
168 NASAL CONGESTION 387
169 RHINORRHOEA 386
170 DISORIENTATION 385
171 CARDIO-RESPIRATORY ARREST 374
172 RENAL IMPAIRMENT 372
173 MENTAL DISORDER 367
174 TINNITUS 366
175 MYOCARDIAL INFARCTION 363
176 HAEMOGLOBIN DECREASED 360
177 MATERNAL EXPOSURE DURING PREGNANCY 358
178 WHITE BLOOD CELL COUNT DECREASED 358
179 WHEEZING 357
180 PLATELET COUNT DECREASED 356
181 TREATMENT FAILURE 353
182 URINARY RETENTION 353
183 CELLULITIS 351
184 BURNING SENSATION 350
185 SURGERY 350
186 ALANINE AMINOTRANSFERASE INCREASED 346
187 ELECTROCARDIOGRAM QT PROLONGED 346
188 NEURALGIA 344
189 HERPES ZOSTER 343
190 DRUG DEPENDENCE 342
191 EMOTIONAL DISTRESS 339
192 LETHARGY 339
193 FEELING HOT 337
194 ADVERSE DRUG REACTION 336
195 CRYING 334
196 DIABETES MELLITUS 332
197 ANGIOEDEMA 330
198 ARTHROPATHY 330
199 PULMONARY EMBOLISM 330
200 UPPER RESPIRATORY TRACT INFECTION 327
201 PRODUCT DOSE OMISSION 326
202 THROMBOCYTOPENIA 325
203 HALLUCINATION, VISUAL 323
204 DISEASE PROGRESSION 322
205 ANGER 321
206 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 321
207 THERAPY CESSATION 318
208 DISCOMFORT 317
209 MEDICATION ERROR 313
210 SPEECH DISORDER 311
211 SKIN EXFOLIATION 310
212 HEPATIC ENZYME INCREASED 305
213 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 304
214 RESPIRATORY FAILURE 302
215 RESTLESSNESS 302
216 CARDIAC DISORDER 301
217 DRY EYE 300
218 THERAPY NON-RESPONDER 300
219 AGGRESSION 299
220 INFUSION RELATED REACTION 298
221 BLOOD PRESSURE DECREASED 297
222 FLATULENCE 293
223 CATARACT 291
224 LOWER RESPIRATORY TRACT INFECTION 291
225 THROAT IRRITATION 291
226 PRODUCTIVE COUGH 289
227 PSYCHOTIC DISORDER 288
228 NERVOUSNESS 286
229 MUSCULOSKELETAL PAIN 285
230 THERAPEUTIC RESPONSE DECREASED 279
231 EXPOSURE DURING PREGNANCY 276
232 THROMBOSIS 276
233 HYPOKALAEMIA 275
234 INTENTIONAL SELF-INJURY 275
235 GAIT INABILITY 274
236 RESPIRATORY ARREST 274
237 UNEVALUABLE EVENT 273
238 URINARY INCONTINENCE 272
239 BLOOD PRESSURE FLUCTUATION 271
240 INFLAMMATION 271
241 HEAD INJURY 270
242 IMPAIRED GASTRIC EMPTYING 269
243 BONE PAIN 264
244 HYPERSOMNIA 260
245 BLOOD POTASSIUM DECREASED 258
246 GASTROINTESTINAL HAEMORRHAGE 258
247 EPISTAXIS 256
248 MOVEMENT DISORDER 256
249 RESTLESS LEGS SYNDROME 256
250 CARDIAC FAILURE 255
251 BLISTER 254
252 STOMATITIS 254
253 HAEMORRHAGE 253
254 BRADYCARDIA 252
255 ENCEPHALOPATHY 252
256 INJECTION SITE BRUISING 252
257 INJECTION SITE ERYTHEMA 252
258 DYSARTHRIA 249
259 BLOOD CREATININE INCREASED 248
260 OSTEOPOROSIS 248
261 RHABDOMYOLYSIS 248
262 PRODUCT DOSE OMISSION IN ERROR 247
263 TREATMENT NONCOMPLIANCE 245
264 RASH PRURITIC 244
265 C-REACTIVE PROTEIN INCREASED 242
266 CROHN^S DISEASE 242
267 SLEEP APNOEA SYNDROME 240
268 PANIC ATTACK 239
269 DYSPNOEA EXERTIONAL 238
270 DYSSTASIA 237
271 WHITE BLOOD CELL COUNT INCREASED 237
272 CYSTITIS 235
273 AFFECTIVE DISORDER 234
274 ANAPHYLACTIC REACTION 233
275 INTENTIONAL DOSE OMISSION 233
276 NIGHT SWEATS 233
277 RESPIRATORY DEPRESSION 233
278 HAEMATOCHEZIA 231
279 LIMB INJURY 231
280 PRODUCT QUALITY ISSUE 231
281 DEVICE ISSUE 230
282 DYSURIA 230
283 HYPOXIA 229
284 RENAL INJURY 229
285 UNDERDOSE 229
286 DEMENTIA 228
287 MENTAL STATUS CHANGES 228
288 DYSGEUSIA 226
289 INTERVERTEBRAL DISC PROTRUSION 226
290 NO ADVERSE EVENT 225
291 FLUID RETENTION 224
292 ABNORMAL BEHAVIOUR 223
293 ASPARTATE AMINOTRANSFERASE INCREASED 223
294 LIMB DISCOMFORT 223
295 MYOCLONUS 223
296 UNRESPONSIVE TO STIMULI 222
297 ANHEDONIA 221
298 BRAIN FOG 220
299 HYPOTHYROIDISM 220
300 CARDIAC FAILURE CONGESTIVE 217
301 EYE IRRITATION 217
302 TYPE 2 DIABETES MELLITUS 217
303 LUNG DISORDER 216
304 PULMONARY OEDEMA 216
305 APHASIA 212
306 MOOD SWINGS 212
307 HALLUCINATION, AUDITORY 207
308 LEUKOPENIA 207
309 POOR QUALITY SLEEP 206
310 POLLAKIURIA 204
311 EXTRAPYRAMIDAL DISORDER 203
312 ORTHOSTATIC HYPOTENSION 203
313 THERAPEUTIC PRODUCT EFFECT DECREASED 203
314 BLOOD GLUCOSE DECREASED 202
315 RIB FRACTURE 202
316 DRUG-INDUCED LIVER INJURY 200
317 METABOLIC ACIDOSIS 200
318 ROAD TRAFFIC ACCIDENT 200
319 ECZEMA 199
320 ACCIDENTAL EXPOSURE TO PRODUCT 197
321 BLOOD CHOLESTEROL INCREASED 196
322 INJECTION SITE PRURITUS 195
323 MENTAL IMPAIRMENT 195
324 ANKYLOSING SPONDYLITIS 194
325 OEDEMA 194
326 HYPOACUSIS 192
327 IRRITABLE BOWEL SYNDROME 192
328 PARANOIA 192
329 THINKING ABNORMAL 191
330 PANCREATITIS 190
331 ABORTION SPONTANEOUS 189
332 PLEURAL EFFUSION 189
333 IMPAIRED QUALITY OF LIFE 187
334 THERAPEUTIC RESPONSE SHORTENED 187
335 POISONING 186
336 ADVERSE EVENT 185
337 MALIGNANT NEOPLASM PROGRESSION 185
338 DERMATITIS ATOPIC 184
339 ABNORMAL DREAMS 183
340 INJECTION SITE SWELLING 183
341 RESPIRATORY DISORDER 183
342 INTESTINAL OBSTRUCTION 182
343 SUSPECTED SUICIDE 182
344 DYSTONIA 181
345 CONTRAINDICATED PRODUCT ADMINISTERED 180
346 HYPERKALAEMIA 179
347 DEEP VEIN THROMBOSIS 178
348 END STAGE RENAL DISEASE 178
349 HEPATIC FUNCTION ABNORMAL 178
350 PRODUCT PRESCRIBING ERROR 178
351 RENAL DISORDER 178
352 HYPOPHAGIA 176
353 HEART RATE DECREASED 175
354 MUSCLE TWITCHING 175
355 SKIN DISCOLOURATION 175
356 HYPOGLYCAEMIA 174
357 COLITIS 173
358 SINUS TACHYCARDIA 172
359 ELECTRIC SHOCK SENSATION 171
360 LOCALISED INFECTION 171
361 MANIA 171
362 ORAL PAIN 171
363 TARDIVE DYSKINESIA 171
364 ACNE 170
365 LIVER DISORDER 170
366 NEUROLEPTIC MALIGNANT SYNDROME 170
367 ALTERED STATE OF CONSCIOUSNESS 169
368 DIPLOPIA 169
369 POST-TRAUMATIC STRESS DISORDER 169
370 JOINT STIFFNESS 168
371 COORDINATION ABNORMAL 167
372 DISEASE RECURRENCE 167
373 LEUKOCYTOSIS 167
374 ANKLE FRACTURE 165
375 INJECTION SITE REACTION 165
376 BLOOD CREATINE PHOSPHOKINASE INCREASED 164
377 PHOTOPHOBIA 164
378 SYSTEMIC LUPUS ERYTHEMATOSUS 164
379 ACCIDENTAL OVERDOSE 163
380 DIVERTICULITIS 163
381 HIP FRACTURE 163
382 PAIN IN JAW 163
383 NEUTROPHIL COUNT INCREASED 162
384 PRODUCT ADMINISTRATION INTERRUPTED 161
385 MOOD ALTERED 160
386 APATHY 159
387 LYMPHOCYTE COUNT DECREASED 159
388 MUCOSAL INFLAMMATION 159
389 MYDRIASIS 159
390 DRUG LEVEL INCREASED 158
391 INJURY 158
392 INTERSTITIAL LUNG DISEASE 158
393 SKIN DISORDER 158
394 STAPHYLOCOCCAL INFECTION 158
395 VITAMIN D DEFICIENCY 158
396 COLITIS MICROSCOPIC 157
397 RED BLOOD CELL COUNT DECREASED 157
398 FOOT FRACTURE 156
399 DELUSION 155
400 NEOPLASM MALIGNANT 153
401 BLOOD PRESSURE SYSTOLIC INCREASED 151
402 LIP SWELLING 151
403 ARRHYTHMIA 150
404 EMOTIONAL DISORDER 149
405 FUNGAL INFECTION 149
406 SEASONAL ALLERGY 149
407 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 149
408 LIVER FUNCTION TEST ABNORMAL 148
409 RASH MACULAR 148
410 SOPOR 148
411 ILL-DEFINED DISORDER 147
412 PSYCHOMOTOR HYPERACTIVITY 147
413 SCIATICA 147
414 ANGINA PECTORIS 146
415 BLOOD ALKALINE PHOSPHATASE INCREASED 146
416 MUSCULOSKELETAL DISCOMFORT 146
417 RESPIRATORY TRACT INFECTION 146
418 TASTE DISORDER 146
419 FEELING COLD 145
420 KNEE ARTHROPLASTY 145
421 SEPTIC SHOCK 145
422 SKIN ULCER 145
423 THERAPEUTIC RESPONSE UNEXPECTED 145
424 VIRAL INFECTION 145
425 HEPATIC STEATOSIS 144
426 HYPOKINESIA 144
427 EAR INFECTION 143
428 RETCHING 143
429 HAEMATEMESIS 142
430 SENSORY DISTURBANCE 142
431 INITIAL INSOMNIA 141
432 INSURANCE ISSUE 141
433 MIDDLE INSOMNIA 141
434 OCULAR HYPERAEMIA 141
435 PARKINSON^S DISEASE 141
436 BLINDNESS 140
437 CHOLELITHIASIS 139
438 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 139
439 OBESITY 139
440 SARS-COV-2 TEST POSITIVE 139
441 WOUND 139
442 BACK DISORDER 138
443 DRUG EFFECT DECREASED 138
444 EYE DISORDER 138
445 KIDNEY INFECTION 138
446 RASH ERYTHEMATOUS 138
447 ROTATOR CUFF SYNDROME 138
448 HAEMATOMA 136
449 GASTRITIS 135
450 JOINT INJURY 135
451 PRODUCT ADMINISTRATION ERROR 135
452 SKIN LESION 135
453 EPILEPSY 134
454 GASTROENTERITIS VIRAL 134
455 TRANSIENT ISCHAEMIC ATTACK 134
456 ACUTE RESPIRATORY FAILURE 133
457 DEVICE MALFUNCTION 133
458 FEAR 133
459 PALLOR 133
460 SPINAL OPERATION 132
461 MAJOR DEPRESSION 131
462 POISONING DELIBERATE 130
463 EYE SWELLING 129
464 MIOSIS 129
465 GLYCOSYLATED HAEMOGLOBIN INCREASED 128
466 HYPERGLYCAEMIA 128
467 LYMPHADENOPATHY 127
468 ORAL HERPES 127
469 SEXUAL DYSFUNCTION 127
470 HEAD DISCOMFORT 126
471 MUSCLE RIGIDITY 126
472 PLASMA CELL MYELOMA 126
473 SPINAL DISORDER 126
474 CARPAL TUNNEL SYNDROME 125
475 CEREBRAL HAEMORRHAGE 125
476 INTERVERTEBRAL DISC DEGENERATION 125
477 PROCEDURAL PAIN 125
478 BURSITIS 124
479 LIVER FUNCTION TEST INCREASED 124
480 LIVER INJURY 124
481 LOWER LIMB FRACTURE 124
482 NERVOUS SYSTEM DISORDER 124
483 SINUS DISORDER 124
484 FREQUENT BOWEL MOVEMENTS 123
485 PANCYTOPENIA 123
486 HYPERREFLEXIA 122
487 INJECTION SITE HAEMORRHAGE 122
488 SPINAL PAIN 122
489 BLOOD URINE PRESENT 121
490 FEBRILE NEUTROPENIA 121
491 GASTRIC DISORDER 121
492 PARKINSONISM 121
493 COLITIS ULCERATIVE 120
494 NEPHROGENIC ANAEMIA 120
495 OSTEOPENIA 120
496 PRESYNCOPE 120
497 RECTAL HAEMORRHAGE 120
498 BREAST CANCER 119
499 FEMUR FRACTURE 119
500 QUALITY OF LIFE DECREASED 119
501 THIRST 119
502 ACUTE MYOCARDIAL INFARCTION 118
503 BLOOD IRON DECREASED 117
504 MUSCLE TIGHTNESS 117
505 TUBULOINTERSTITIAL NEPHRITIS 117
506 ULCER 117
507 DIABETIC KETOACIDOSIS 116
508 EAR PAIN 116
509 LACTIC ACIDOSIS 116
510 SPINAL FRACTURE 116
511 AKATHISIA 115
512 POST PROCEDURAL COMPLICATION 115
513 SPINAL OSTEOARTHRITIS 115
514 SYNOVITIS 115
515 IMMUNODEFICIENCY 114
516 NEUTROPHIL COUNT DECREASED 114
517 SCHIZOPHRENIA 114
518 TEMPERATURE INTOLERANCE 114
519 HAEMATURIA 113
520 THROAT TIGHTNESS 113
521 TOOTHACHE 113
522 BLOOD SODIUM DECREASED 112
523 EATING DISORDER 112
524 HEART RATE IRREGULAR 112
525 ABDOMINAL PAIN LOWER 111
526 ARTERIOSCLEROSIS CORONARY ARTERY 111
527 BLOOD PRESSURE ABNORMAL 111
528 BLOOD UREA INCREASED 111
529 FEELING JITTERY 111
530 HEPATIC FAILURE 111
531 INFUSION SITE PAIN 110
532 ANXIETY DISORDER 109
533 IMPAIRED HEALING 109
534 NOCTURIA 109
535 PULMONARY CONGESTION 109
536 GENERALISED TONIC-CLONIC SEIZURE 108
537 PRODUCT AVAILABILITY ISSUE 108
538 ADRENAL INSUFFICIENCY 107
539 BLOOD TEST ABNORMAL 107
540 CONCUSSION 107
541 FEEDING DISORDER 107
542 FRACTURE 107
543 IMPAIRED WORK ABILITY 107
544 INCREASED APPETITE 107
545 UPPER GASTROINTESTINAL HAEMORRHAGE 107
546 EYE PRURITUS 106
547 DRUG EFFECT INCOMPLETE 105
548 VAGINAL HAEMORRHAGE 105
549 AFFECT LABILITY 104
550 ANAL INCONTINENCE 104
551 BRADYPHRENIA 104
552 HERNIA 104
553 MUSCULOSKELETAL DISORDER 104
554 PNEUMONITIS 104
555 SKIN HAEMORRHAGE 104
556 TOOTH DISORDER 104
557 UPPER LIMB FRACTURE 104
558 CARDIOMEGALY 103
559 CYST 103
560 HAEMORRHOIDS 103
561 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 103
562 THERAPY PARTIAL RESPONDER 103
563 CLONUS 102
564 COVID-19 PNEUMONIA 102
565 MUSCLE SPASTICITY 102
566 CLOSTRIDIUM DIFFICILE INFECTION 101
567 LIGAMENT SPRAIN 101
568 SKIN BURNING SENSATION 101
569 AGEUSIA 100
570 HIATUS HERNIA 100
571 COLD SWEAT 99
572 DEVICE DISLOCATION 99
573 DISSOCIATION 99
574 ERECTILE DYSFUNCTION 99
575 INJECTION SITE MASS 99
576 NEEDLE ISSUE 99
577 CANDIDA INFECTION 98
578 HIP ARTHROPLASTY 98
579 HYPERAESTHESIA 97
580 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 97
581 MICTURITION URGENCY 97
582 NEUROTOXICITY 97
583 PRODUCT STORAGE ERROR 97
584 PULMONARY MASS 97
585 ASPIRATION 96
586 DIZZINESS POSTURAL 96
587 MOUTH ULCERATION 96
588 NEOPLASM PROGRESSION 96
589 BODY TEMPERATURE DECREASED 95
590 CHROMATURIA 95
591 DECREASED ACTIVITY 95
592 OBSTRUCTIVE AIRWAYS DISORDER 95
593 PRODUCT ADHESION ISSUE 95
594 SCAR 95
595 ACUTE RESPIRATORY DISTRESS SYNDROME 94
596 BLOOD URIC ACID INCREASED 94
597 CIRCULATORY COLLAPSE 94
598 MULTIPLE ORGAN DYSFUNCTION SYNDROME 94
599 RED BLOOD CELL SEDIMENTATION RATE INCREASED 94
600 BLADDER DISORDER 93
601 GASTROINTESTINAL PAIN 93
602 LACRIMATION INCREASED 93
603 MUSCULOSKELETAL CHEST PAIN 93
604 NERVE COMPRESSION 93
605 OSTEOMYELITIS 93
606 SUBDURAL HAEMATOMA 93
607 APHONIA 92
608 HEPATITIS 92
609 SKIN FISSURES 92
610 TENDONITIS 92
611 ATELECTASIS 91
612 BONE DENSITY DECREASED 90
613 DRUG EFFECT LESS THAN EXPECTED 90
614 DRUG TOXICITY 90
615 HAEMOPTYSIS 90
616 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 90
617 INCONTINENCE 90
618 JOINT NOISE 90
619 FOOT DEFORMITY 89
620 FULL BLOOD COUNT DECREASED 89
621 HEPATIC CYTOLYSIS 89
622 TOOTH INFECTION 89
623 ATAXIA 88
624 GAMMA-GLUTAMYLTRANSFERASE INCREASED 88
625 GASTRIC ULCER 88
626 PANCREATITIS ACUTE 88
627 BIPOLAR DISORDER 87
628 FAECES DISCOLOURED 87
629 HYPERLIPIDAEMIA 87
630 HYPERTENSIVE CRISIS 87
631 NERVE INJURY 87
632 THYROID DISORDER 87
633 TOOTH LOSS 87
634 BACTERIAL INFECTION 86
635 FEELING OF DESPAIR 86
636 INFUSION SITE ERYTHEMA 86
637 PRODUCT PRESCRIBING ISSUE 86
638 SKIN LACERATION 86
639 SNEEZING 86
640 BODY TEMPERATURE INCREASED 85
641 BRAIN INJURY 85
642 EOSINOPHILIA 85
643 HEMIPARESIS 85
644 LUNG NEOPLASM MALIGNANT 85
645 PAIN OF SKIN 85
646 TACHYPNOEA 85
647 MUSCLE STRAIN 84
648 PRESCRIBED UNDERDOSE 84
649 RESPIRATORY DISTRESS 84
650 BEDRIDDEN 83
651 HAEMATOCRIT DECREASED 83
652 JAUNDICE 83
653 SKIN IRRITATION 83
654 HYPERTHERMIA 82
655 HYPOTHERMIA 82
656 PERIPHERAL COLDNESS 82
657 PHOTOSENSITIVITY REACTION 82
658 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 82
659 RASH PAPULAR 82
660 REBOUND ACID HYPERSECRETION 82
661 SPINAL STENOSIS 82
662 APNOEA 81
663 BRUXISM 81
664 EXPOSURE VIA SKIN CONTACT 81
665 HEPATIC CIRRHOSIS 81
666 HYPOAESTHESIA ORAL 81
667 IMMUNE SYSTEM DISORDER 81
668 MATERNAL EXPOSURE DURING BREAST FEEDING 81
669 OCULAR DISCOMFORT 81
670 PERICARDIAL EFFUSION 81
671 RESPIRATORY TRACT CONGESTION 81
672 SUBARACHNOID HAEMORRHAGE 81
673 CHOKING 80
674 INJECTION SITE RASH 80
675 PRESCRIBED OVERDOSE 80
676 PRODUCT DISTRIBUTION ISSUE 80
677 WRIST FRACTURE 80
678 BLOOD PRESSURE SYSTOLIC DECREASED 79
679 BONE DISORDER 79
680 DERMATITIS CONTACT 79
681 HYSTERECTOMY 79
682 IRON DEFICIENCY ANAEMIA 79
683 JOINT RANGE OF MOTION DECREASED 79
684 SMALL INTESTINAL OBSTRUCTION 79
685 BLOOD TRIGLYCERIDES INCREASED 78
686 EAR DISCOMFORT 78
687 FEELING DRUNK 78
688 FOOD POISONING 78
689 SCRATCH 78
690 DRUG DOSE OMISSION BY DEVICE 77
691 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 77
692 HYPERPARATHYROIDISM SECONDARY 77
693 INTERNATIONAL NORMALISED RATIO INCREASED 77
694 LYMPHOEDEMA 77
695 LYMPHOPENIA 77
696 PULMONARY HYPERTENSION 77
697 VENTRICULAR TACHYCARDIA 77
698 VITAMIN B12 DECREASED 77
699 BLOOD POTASSIUM INCREASED 76
700 COMA SCALE ABNORMAL 76
701 LABORATORY TEST ABNORMAL 76
702 NASAL TURBINATE HYPERTROPHY 76
703 OSTEONECROSIS 76
704 POTENTIATING DRUG INTERACTION 76
705 UROSEPSIS 76
706 ATRIAL SEPTAL DEFECT 75
707 PAROSMIA 75
708 DEMYELINATION 74
709 ELECTROLYTE IMBALANCE 74
710 EXTRA DOSE ADMINISTERED 74
711 MELAENA 74
712 TENDON RUPTURE 74
713 VITAMIN B12 DEFICIENCY 74
714 CYANOSIS 73
715 DRUG RESISTANCE 73
716 EXOSTOSIS 73
717 FACIAL PAIN 73
718 LIBIDO DECREASED 73
719 TRANSAMINASES INCREASED 73
720 APHTHOUS ULCER 72
721 CARDIOGENIC SHOCK 72
722 DEPRESSIVE SYMPTOM 72
723 DRUG PRESCRIBING ERROR 72
724 IMPAIRED DRIVING ABILITY 72
725 INTERVERTEBRAL DISCITIS 72
726 MACULAR DEGENERATION 72
727 PARALYSIS 72
728 PELVIC PAIN 72
729 SLUGGISHNESS 72
730 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 72
731 JOINT EFFUSION 71
732 MASS 71
733 ORAL CANDIDIASIS 71
734 RHINITIS 71
735 SENSITIVITY TO WEATHER CHANGE 71
736 BRAIN OEDEMA 70
737 CHOLECYSTECTOMY 70
738 DELUSION OF GRANDEUR 70
739 GLOSSODYNIA 69
740 GRIP STRENGTH DECREASED 69
741 HALLUCINATIONS, MIXED 69
742 LOSS OF LIBIDO 69
743 BRADYKINESIA 68
744 CENTRAL NERVOUS SYSTEM LESION 68
745 CHOLECYSTITIS ACUTE 68
746 DEAFNESS 68
747 GROIN PAIN 68
748 HYPERCALCAEMIA 68
749 PERSONALITY DISORDER 68
750 PRODUCT PHYSICAL ISSUE 68
751 RED CELL DISTRIBUTION WIDTH INCREASED 68
752 STEVENS-JOHNSON SYNDROME 68
753 WEIGHT FLUCTUATION 68
754 BODY HEIGHT DECREASED 67
755 BREATH SOUNDS ABNORMAL 67
756 DEVICE DIFFICULT TO USE 67
757 DEVICE LEAKAGE 67
758 ECONOMIC PROBLEM 67
759 ELECTRIC SHOCK 67
760 FRUSTRATION TOLERANCE DECREASED 67
761 INCORRECT PRODUCT ADMINISTRATION DURATION 67
762 MONOCYTE COUNT INCREASED 67
763 PRE-ECLAMPSIA 67
764 SOMATIC SYMPTOM DISORDER 67
765 WOUND INFECTION 67
766 BLOOD PRESSURE DIASTOLIC DECREASED 66
767 CHOLESTASIS 66
768 DACTYLITIS 66
769 HEPATOTOXICITY 66
770 HOSPICE CARE 66
771 HYPOMANIA 66
772 HYPOTONIA 66
773 PHARYNGEAL SWELLING 66
774 RESPIRATION ABNORMAL 66
775 RHINALGIA 66
776 SUPRAVENTRICULAR TACHYCARDIA 66
777 TROPONIN INCREASED 66
778 DERMATITIS 65
779 DERMATITIS ALLERGIC 65
780 EYE INFECTION 65
781 GOUT 65
782 MULTIPLE ALLERGIES 65
783 PARAESTHESIA ORAL 65
784 TOXIC ENCEPHALOPATHY 65
785 VITAMIN D DECREASED 65
786 DECREASED INTEREST 64
787 GASTROENTERITIS 64
788 GLAUCOMA 64
789 INJECTION SITE WARMTH 64
790 ORAL DISCOMFORT 64
791 PRODUCT DISPENSING ERROR 64
792 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 64
793 RHEUMATOID FACTOR INCREASED 64
794 SENSORY LOSS 64
795 SINUS CONGESTION 64
796 TOOTH EXTRACTION 64
797 TOOTH FRACTURE 64
798 BEZOAR 63
799 CONJUNCTIVITIS 63
800 DENTAL CARIES 63
801 EUPHORIC MOOD 63
802 EXPOSURE VIA BREAST MILK 63
803 MENISCUS INJURY 63
804 POST PROCEDURAL INFECTION 63
805 SUBSTANCE ABUSE 63
806 VISUAL ACUITY REDUCED 63
807 WALKING AID USER 63
808 CLOSTRIDIUM DIFFICILE COLITIS 62
809 GASTROINTESTINAL INFECTION 62
810 INFUSION SITE SWELLING 62
811 INJECTION SITE URTICARIA 62
812 POOR VENOUS ACCESS 62
813 PRODUCT USE COMPLAINT 62
814 GALLBLADDER DISORDER 61
815 POLYURIA 61
816 PULMONARY MALFORMATION 61
817 SELF-INJURIOUS IDEATION 61
818 SKIN INFECTION 61
819 THROAT CLEARING 61
820 VENTRICULAR FIBRILLATION 61
821 VENTRICULAR SEPTAL DEFECT 61
822 BACK INJURY 60
823 ERUCTATION 60
824 PERITONITIS 60
825 ACUTE HEPATIC FAILURE 59
826 DRUG ERUPTION 59
827 FACIAL PARALYSIS 59
828 IMMUNOSUPPRESSION 59
829 KNEE OPERATION 59
830 MOTOR DYSFUNCTION 59
831 PRE-EXISTING CONDITION IMPROVED 59
832 RENAL TUBULAR NECROSIS 59
833 TRIGEMINAL NEURALGIA 59
834 BEHAVIOUR DISORDER 58
835 CERVICAL VERTEBRAL FRACTURE 58
836 CORONARY ARTERY DISEASE 58
837 DEVICE RELATED INFECTION 58
838 FULL BLOOD COUNT ABNORMAL 58
839 GLOMERULAR FILTRATION RATE DECREASED 58
840 HYPERCHOLESTEROLAEMIA 58
841 LOSS OF CONTROL OF LEGS 58
842 NYSTAGMUS 58
843 SHOCK 58
844 THERAPY CHANGE 58
845 VITAMIN B12 INCREASED 58
846 BLOOD MAGNESIUM DECREASED 57
847 GENERALISED OEDEMA 57
848 HYPERVENTILATION 57
849 INCREASED TENDENCY TO BRUISE 57
850 ON AND OFF PHENOMENON 57
851 PANIC REACTION 57
852 PREMATURE BABY 57
853 RESPIRATORY SYNCYTIAL VIRUS INFECTION 57
854 SENSATION OF FOREIGN BODY 57
855 ABSCESS 56
856 DISABILITY 56
857 HAND FRACTURE 56
858 HEPATIC ENCEPHALOPATHY 56
859 HYPERAMMONAEMIA 56
860 ILEUS 56
861 LUMBAR VERTEBRAL FRACTURE 56
862 LYMPHOCYTE COUNT ABNORMAL 56
863 NODULE 56
864 OROPHARYNGEAL DISCOMFORT 56
865 PELVIC FRACTURE 56
866 PERONEAL NERVE PALSY 56
867 SKIN CANCER 56
868 SNORING 56
869 SOMNAMBULISM 56
870 MALNUTRITION 55
871 METASTASES TO LIVER 55
872 MUSCLE ATROPHY 55
873 NEUROLOGICAL SYMPTOM 55
874 PULMONARY FIBROSIS 55
875 TRISMUS 55
876 ARTERIOSCLEROSIS 54
877 BLOOD COUNT ABNORMAL 54
878 BLOOD GLUCOSE FLUCTUATION 54
879 DIABETES MELLITUS INADEQUATE CONTROL 54
880 NEPHROPATHY TOXIC 54
881 PERSONALITY CHANGE 54
882 POLYDIPSIA 54
883 PRODUCT USED FOR UNKNOWN INDICATION 54
884 PSYCHIATRIC SYMPTOM 54
885 SPUTUM DISCOLOURED 54
886 TEARFULNESS 54
887 TOOTH ABSCESS 54
888 URINE ODOUR ABNORMAL 54
889 CLEFT PALATE 53
890 CORONARY ARTERY OCCLUSION 53
891 GRANULOMA 53
892 INABILITY TO AFFORD MEDICATION 53
893 MYOFASCIAL PAIN SYNDROME 53
894 RENAL PAIN 53
895 REVERSIBLE AIRWAYS OBSTRUCTION 53
896 UPPER-AIRWAY COUGH SYNDROME 53
897 ACTIVITIES OF DAILY LIVING IMPAIRED 52
898 ARTHROPOD BITE 52
899 DEPRESSION SUICIDAL 52
900 DRUG USE DISORDER 52
901 DYSPHORIA 52
902 EXPIRED PRODUCT ADMINISTERED 52
903 GLUCOSE TOLERANCE IMPAIRED 52
904 HUMERUS FRACTURE 52
905 PHARYNGITIS STREPTOCOCCAL 52
906 SECRETION DISCHARGE 52
907 TENSION HEADACHE 52
908 VITREOUS FLOATERS 52
909 WHITE BLOOD CELLS URINE POSITIVE 52
910 ASPHYXIA 51
911 BLOOD IMMUNOGLOBULIN A INCREASED 51
912 BRONCHOSPASM 51
913 CEREBRAL DISORDER 51
914 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 51
915 EMPHYSEMA 51
916 GLOMERULAR FILTRATION RATE INCREASED 51
917 ORAL DISORDER 51
918 POLYNEUROPATHY 51
919 SCREAMING 51
920 SKIN ABRASION 51
921 SOCIAL AVOIDANT BEHAVIOUR 51
922 TRIGGER FINGER 51
923 BLOOD GLUCOSE ABNORMAL 50
924 CHOLECYSTITIS 50
925 DEVICE BREAKAGE 50
926 GRANULOCYTE COUNT INCREASED 50
927 ISCHAEMIC STROKE 50
928 JOINT DISLOCATION 50
929 MOUTH SWELLING 50
930 PRODUCT MONITORING ERROR 50
931 STATUS EPILEPTICUS 50
932 STRESS CARDIOMYOPATHY 50
933 ACCIDENT 49
934 AUTONOMIC NERVOUS SYSTEM IMBALANCE 49
935 BLOOD BILIRUBIN INCREASED 49
936 DECREASED IMMUNE RESPONSIVENESS 49
937 DEFAECATION URGENCY 49
938 FAECALOMA 49
939 FOOD ALLERGY 49
940 GASTROINTESTINAL HYPOMOTILITY 49
941 HEREDITARY ANGIOEDEMA 49
942 HYPERTONIA 49
943 HYPOCALCAEMIA 49
944 MULTIPLE DRUG THERAPY 49
945 MYOCARDITIS 49
946 NEUTROPHILIA 49
947 POST CHOLECYSTECTOMY SYNDROME 49
948 RHONCHI 49
949 SCOLIOSIS 49
950 SQUAMOUS CELL CARCINOMA 49
951 BREAST PAIN 48
952 DIABETIC NEUROPATHY 48
953 DRY THROAT 48
954 GINGIVAL BLEEDING 48
955 HAEMODYNAMIC INSTABILITY 48
956 HYPOMAGNESAEMIA 48
957 MYOPATHY 48
958 PULMONARY THROMBOSIS 48
959 RASH MACULO-PAPULAR 48
960 RESPIRATORY DISORDER NEONATAL 48
961 TENDERNESS 48
962 THERAPEUTIC RESPONSE CHANGED 48
963 ASCITES 47
964 BLOOD PHOSPHORUS DECREASED 47
965 CYTOKINE RELEASE SYNDROME 47
966 CYTOPENIA 47
967 EYE MOVEMENT DISORDER 47
968 GINGIVAL PAIN 47
969 HYPOVOLAEMIA 47
970 LARYNGITIS 47
971 PATHOLOGICAL FRACTURE 47
972 PHARYNGITIS 47
973 PNEUMOTHORAX 47
974 PSYCHOLOGICAL TRAUMA 47
975 SALIVARY HYPERSECRETION 47
976 SPONDYLITIS 47
977 ABNORMAL LOSS OF WEIGHT 46
978 BASAL CELL CARCINOMA 46
979 BRONCHIAL DISORDER 46
980 BRONCHIAL HAEMORRHAGE 46
981 BRONCHIAL NEOPLASM 46
982 DEVICE DELIVERY SYSTEM ISSUE 46
983 ENDOMETRIAL ABLATION 46
984 EYE HAEMORRHAGE 46
985 FACE OEDEMA 46
986 FAECES SOFT 46
987 FURUNCLE 46
988 GENITAL PAIN 46
989 HYPERNATRAEMIA 46
990 INFUSION SITE EXTRAVASATION 46
991 OESOPHAGITIS 46
992 PLATELET COUNT INCREASED 46
993 TENDON DISORDER 46
994 TENSION 46
995 ACUTE CORONARY SYNDROME 45
996 APPLICATION SITE ERYTHEMA 45
997 BLINDNESS UNILATERAL 45
998 DEVICE OCCLUSION 45
999 HAIR COLOUR CHANGES 45